CN Energy Group에 대한 매도 수량은 투자자에게 CN Energy Group의 주식 하락에 베팅하는 정도를 알려줍니다. 매도 수량 데이터는 2주마다 업데이트됩니다.

CN Energy Group (NASDAQ:CNEY) 주식, 공매도 수량 보고

CN Energy Group Inc along with its subsidiaries is a manufacturer and supplier of wood-based activated carbon that is used in pharmaceutical manufacturing, industrial manufacturing, water purification, environmental protection, and food and beverage production and a producer of biomass electricity generated in the process of producing activated carbon. The firm generates a majority of its revenue from Activated carbon.

CN Energy Group

Exclusives

Trading Ideas

AAPL

AMZN

APLD

CNEY

GLMD

GOVX

IMRX

INTC

LUMN

LUNR

NDRA

NVDA

PLTR

SMCI

SMMT

TNON

TSLA

WHLR

매일 거래일마다 벤징가 프로(Benzinga Pro)에서 수백 개의 헤드라인과 보도자료가 올라온다. 이는 트레이더들이 전체 시장 및 개별 종목에 대한 최신 뉴스를 확인할 수 있는 소스이다. 2024년 9월에 Benzinga Pro에서 가장 많이 검색된 주식들을 살펴보겠다. 현재 가격과 연초 대비 성과는 9월 30일 기준이며 배당금은 포함되지 않았다.

독점: 9월 벤징가 프로에서 가장 많이 검색된 상위 20개 티커 - 테슬라, 엔비디아, 애플은 어디에?

CN Energy Group Inc. - Class A Ordinary Shares

CN Energy Group Inc

Burlington Stores, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BURL#NYSE">BURL</a>) shares are trading higher in the <a target="_blank" href="https://www.benzinga.com/premarket" rel="noreferrer noopener">premarket session on Thursday</a>.
The company reported fourth-quarter adjusted earnings per share of $4.13, <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/g44161791/burlington-stores-inc-reports-fourth-quarter-and-full-year-2024-earnings" rel="noreferrer noopener">beating the street view of $3.76.</a>
Quarterly sales of $3.28 billion (+5% year over year) outpaced the analyst consensus estimate of $3.23 billion. Comparable store sales growth for the quarter was 6%, versus&nbsp;guidance&nbsp;of&nbsp;0%&nbsp;to&nbsp;2%.
&#8220;Taking 2024 as a whole, total sales increased 11%, comparable store sales increased 4%, and Adjusted EBIT Margin increased 100 basis points,&#8221; said Michael O&#8217;Sullivan, CEO.&nbsp;
The quarterly gross profit was $1.404 billion, up from $1.333 billion in the year-ago period. Gross margin expanded by 30 basis points to 42.9%, freight improved by 20 basis points, and merchandise margin increased by 10 basis points.
Adjusted EBITDA&nbsp;was $456 million in the quarter under review, higher than $412 million in the year-ago period.
Also Read:<a target="_blank" href="https://www.benzinga.com/news/large-cap/25/03/44161401/rio-tintos-1-8-billion-iron-ore-expansion-ramps-up-in-australia-details" rel="noreferrer noopener"> Rio Tinto&#8217;s $1.8 Billion Iron Ore Expansion Ramps Up In Australia: Details</a>
&#8220;We opened 101 net new stores in 2024 and relocated 31 of our older oversized locations,&#8221; the CEO added.
The company ended the fourth quarter with $1.822 billion in liquidity, comprised of $995 million in unrestricted cash.
Outlook: &#8220;The outlook for 2025 is very uncertain and we will plan and manage our business accordingly,&#8221; the CEO said.
The company expects total sales to increase by 6% &#8211; 8%, on top of the 11% increase the prior year. The company sees adjusted EPS of $8.70 &#8211; $9.30 (estimate: $9.43).
Burlington expects first-quarter total sales to increase 5% &#8211; 7%, comparable store sales are expected to be flattish. The company sees adjusted EPS of $1.30 &#8211; $1.45 (estimate: $1.68).
Price Action: BURL shares are trading higher by 12.5% to $266.50 premarket at last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/forex/25/03/44161314/us-stocks-likely-to-open-lower-after-wednesdays-blip-be-patient-but-be-ready-to-act-says-analyst-as-market-uncertainties-can-create-opportunities" target="_blank" rel="noreferrer noopener">US Stocks Likely To Open Lower After Wednesday&#8217;s Blip: &#8216;Be Patient, But Be Ready To Act,&#8217; Says Analyst As Market Uncertainties Can Create &#8216;Opportunities&#8217;</a></li>
</ul>
Photo via Shutterstock.

Earnings

Equities

News

Guidance

Markets

Movers

General

BURL

Burlington Stock Jumps As Q4 Earnings Crush Estimates, But CEO Warns Of 'Uncertain' 2025 Outlook

WIIM

RYAAY

Ryanair shares are trading lower after Morgan Stanley downgraded its rating on the stock from overweight to equal weight.

ADTX

Aditxt'ss Adimune Subsidiary To Ship Drug Substances For Final Drug Product Formulation Of ADI-100 Ahead Of Planned Trials For Type 1 Diabetes And Psoriasis In Germany And Stiff Person Syndrome At Mayo Clinic

B of A Securities analyst Peter Galbo maintains Campbell`s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPB#NASDAQ">CPB</a>) with a Underperform and lowers the price target from $45 to $41.

Price Target

Analyst Ratings

B of A Securities Maintains Underperform on Campbell's, Lowers Price Target to $41

Small Cap Consumer Research analyst Eric Beder reiterates Vera Bradley (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRA#NASDAQ">VRA</a>) with a Buy and maintains $5.5 price target.

Reiteration

Small Cap Consumer Research Reiterates Buy on Vera Bradley, Maintains $5.5 Price Target

VRME

VerifyMe shares are trading lower after the company reported worse-than-expected Q4 earnings and sales.

Contracts

MRAM

Everspin Awarded $10.5M Contract For MRAM IP And Foundry Services For Purdue University's ME Commons In-Memory Compute Project

Baird analyst Shrenik Kothari maintains Zscaler (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZS#NASDAQ">ZS</a>) with a Outperform and raises the price target from $240 to $250.

Baird Maintains Outperform on Zscaler, Raises Price Target to $250

Earnings Beats

Earnings Misses

VYNE

VYNE Therapeutics Q4 2024 GAAP EPS $(0.28) Beats $(0.30) Estimate, Sales $84.000K Miss $140.000K Estimate

Baird analyst Joe Vruwink maintains Veeva Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) with a Outperform and raises the price target from $283 to $285.

VEEV

Baird Maintains Outperform on Veeva Systems, Raises Price Target to $285

ALLR

Allarity Therapeutics Announces ITs Phase 2 Trial Of Stenoparib In Combination With Temozolomide For Recurrent Small Cell Lung Cancer, Being Fully Funded By US Veterans Administration

Baird analyst William Power maintains MongoDB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>) with a Outperform and lowers the price target from $390 to $300.

Baird Maintains Outperform on MongoDB, Lowers Price Target to $300

Curtiss-Wright Receives $18M Follow-On Order From US Marine Corps

No gainer in today's Pre-market session. 
<h3>Losers</h3>
<table>
<thead>
<tr>
<th>Symbol</th>
<th>Name</th>
<th align="right">Price</th>
<th align="right">Change ($)</th>
<th align="right">Change (%)</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>)</td>
<td>SPDR Select Sector Fund - Technology</td>
<td align="right">217.58</td>
<td align="right">-3.99</td>
<td align="right">-1.81</td>
<td>19.4K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>)</td>
<td>SPDR Select Sector Fund - Financial</td>
<td align="right">49.70</td>
<td align="right">-0.51</td>
<td align="right">-1.02</td>
<td>255.6K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>)</td>
<td>SPDR Select Sector Fund - Consumer Discretionary</td>
<td align="right">209.31</td>
<td align="right">-2.10</td>
<td align="right">-1.00</td>
<td>364</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>)</td>
<td>SPDR Select Sector Fund - Utilities</td>
<td align="right">76.95</td>
<td align="right">-0.54</td>
<td align="right">-0.70</td>
<td>5.5K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLV#NYSE">XLV</a>)</td>
<td>SPDR Select Sector Fund - Health Care</td>
<td align="right">148.93</td>
<td align="right">-0.75</td>
<td align="right">-0.51</td>
<td>4.3K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLRE#NYSE">XLRE</a>)</td>
<td>Real Estate Select Sector SPDR Fund (The)</td>
<td align="right">43.20</td>
<td align="right">-0.22</td>
<td align="right">-0.51</td>
<td>1.2K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLP#NYSE">XLP</a>)</td>
<td>SPDR Select Sector Fund - Consumer Staples</td>
<td align="right">82.06</td>
<td align="right">-0.38</td>
<td align="right">-0.47</td>
<td>1.6K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>)</td>
<td>SPDR Select Sector Fund - Energy Select Sector</td>
<td align="right">85.34</td>
<td align="right">-0.36</td>
<td align="right">-0.43</td>
<td>13.3K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLB#NYSE">XLB</a>)</td>
<td>Materials Select Sector SPDR</td>
<td align="right">87.84</td>
<td align="right">-0.20</td>
<td align="right">-0.23</td>
<td>326</td>
</tr>
</tbody>
</table>
<a href="https://pro.benzinga.com/?utm_source=insights">Pulled from Benzinga Pro data</a> this sector movers alerts can help traders understand macro-level market trends. Traders often look for sector movers to provide high-level analysis on which sectors are over- or under-performing to make better investing decisions on exchange traded funds (ETFs) or individual tickers in those sectors. 
To read more about sector movers, <a href="https://www.benzinga.com/movers">click here</a>.

Sector ETFs

Pre-Market Outlook

ETFs

XLRE

Select Sector SPDR-Consumer Discretionary

Leading And Lagging Sectors For March 6, 2025

Tesla shares are trading lower after Baird lowered its price target on the stock from $440 to $370.

Baird analyst Craig Kennison maintains Thor Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THO#NYSE">THO</a>) with a Outperform and lowers the price target from $110 to $100.

Baird Maintains Outperform on Thor Industries, Lowers Price Target to $100

BECN

Beacon Acquires DM Figley, Terms Not Disclosed

CNTM

ConnectM Secured Over 5,500 Orders For MELI Mobility Edge And AURAI Platform Subscriptions From Existing OEM Customers In First Two Months Of 2025

Phathom Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHAT#NASDAQ">PHAT</a>) reported quarterly losses of $(0.79) per share which beat the analyst consensus estimate of $(1.27) by 37.8 percent. This is a 1.25 percent increase over losses of $(0.80) per share from the same period last year. The company reported quarterly sales of $29.66 million which beat the analyst consensus estimate of $24.91 million by 19.09 percent. This is a 4.25K percent increase over sales of $682.00 thousand the same period last year.

PHAT

Phathom Pharmaceuticals Q4 Adj $(0.79) Beats $(1.27) Estimate, Sales $29.66M Beat $24.91M Estimate

Baird analyst Jonathan Komp maintains Foot Locker (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FL#NYSE">FL</a>) with a Neutral and lowers the price target from $24 to $20.

Baird Maintains Neutral on Foot Locker, Lowers Price Target to $20

Commodities

Press Releases

CN Energy Group Receives Re-order from Water Purification Customer for its Activated Carbon

CN Energy Group. Inc. to Present at The Aegis Capital Corp 2024 Virtual Conference

CNEY Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

CNEY Receives Nasdaq Notifications Regarding Minimum Market Value of Publicly Held Shares Requirement

CNEY Regains Compliance with Nasdaq Minimum Market Value of Publicly Held Shares Requirement

CNEY Receives NASDAQ Minimum Bid Price Requirement Extension

Offerings

Small Cap

CNEY Entered into Warrant Inducement Agreements with Certain Holders

AdvanSix

Braskem

Bolt Projects Holdings, Inc. - Common Stock

Bolt Projects Holdings

Cabot

Core Molding Technologies Inc Common Stock

Core Molding Technologies

Gulf Resources

Hawkins

Koppers Holdings

Kronos Worldwide

Loop Industries

Mativ Holdings

Orion

Olin

Origin Materials, Inc. - Class A Common Stock

Origin Mat

PureCycle Technologies, Inc. - Common stock

PureCycle Technologies

Tantech Hldgs

Tronox Holdings

Trinseo

Westlake

Westlake Chemical Partners LP Common Units representing limited partner interests

Westlake Chemical

Comments

CN Energy Group

매도 수량

CN Energy Group (NASDAQ:CNEY) 주식, 공매도 수량 보고

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌